
Daniel Michael Podgorski
Examiner (ID: 7354, Phone: (571)272-6270 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1628 |
| Total Applications | 339 |
| Issued Applications | 186 |
| Pending Applications | 0 |
| Abandoned Applications | 153 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15724195
[patent_doc_number] => 10610511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-07
[patent_title] => Method of treatment
[patent_app_type] => utility
[patent_app_number] => 16/517111
[patent_app_country] => US
[patent_app_date] => 2019-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1271
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16517111
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/517111 | Method of treatment | Jul 18, 2019 | Issued |
Array
(
[id] => 15696675
[patent_doc_number] => 10604504
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-31
[patent_title] => Indole carboxamide compounds
[patent_app_type] => utility
[patent_app_number] => 16/396879
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52411
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16396879
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/396879 | Indole carboxamide compounds | Apr 28, 2019 | Issued |
Array
(
[id] => 15422479
[patent_doc_number] => 10544153
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone, prodrugs, methods of making and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/165194
[patent_app_country] => US
[patent_app_date] => 2018-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 47
[patent_no_of_words] => 12465
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16165194
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/165194 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone, prodrugs, methods of making and use thereof | Oct 18, 2018 | Issued |
Array
(
[id] => 13867459
[patent_doc_number] => 20190030070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => Substances Containing AuCs and Preparation Method and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 16/129896
[patent_app_country] => US
[patent_app_date] => 2018-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16129896
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/129896 | Substances Containing AuCs and Preparation Method and Use Thereof | Sep 12, 2018 | Abandoned |
Array
(
[id] => 15912867
[patent_doc_number] => 10653655
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Composition for preventing or improving peripheral neuropathy
[patent_app_type] => utility
[patent_app_number] => 16/129875
[patent_app_country] => US
[patent_app_date] => 2018-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11205
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16129875
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/129875 | Composition for preventing or improving peripheral neuropathy | Sep 12, 2018 | Issued |
Array
(
[id] => 13777869
[patent_doc_number] => 20190002473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => COMPOUNDS FOR TREATMENT OF PAIN
[patent_app_type] => utility
[patent_app_number] => 16/124816
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16124816
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/124816 | COMPOUNDS FOR TREATMENT OF PAIN | Sep 6, 2018 | Abandoned |
Array
(
[id] => 13993023
[patent_doc_number] => 20190065669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => Dock Derived Compound against Laminin Receptor (37 LR) and Uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/113718
[patent_app_country] => US
[patent_app_date] => 2018-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16113718
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/113718 | Dock derived compound against laminin receptor (37 LR) and uses thereof | Aug 26, 2018 | Issued |
Array
(
[id] => 14388293
[patent_doc_number] => 10307404
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-06-04
[patent_title] => Ocular formulations for drug-delivery to the posterior segment of the eye
[patent_app_type] => utility
[patent_app_number] => 16/042003
[patent_app_country] => US
[patent_app_date] => 2018-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27896
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16042003
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/042003 | Ocular formulations for drug-delivery to the posterior segment of the eye | Jul 22, 2018 | Issued |
Array
(
[id] => 13729553
[patent_doc_number] => 20180369244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment
[patent_app_type] => utility
[patent_app_number] => 16/003032
[patent_app_country] => US
[patent_app_date] => 2018-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56258
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16003032
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/003032 | BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment | Jun 6, 2018 | Abandoned |
Array
(
[id] => 13563713
[patent_doc_number] => 20180333404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => Pharmaceutical composition for prevention or treatment of diabetes or fatty liver comprising CYP4A inhibitor
[patent_app_type] => utility
[patent_app_number] => 15/984258
[patent_app_country] => US
[patent_app_date] => 2018-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6296
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15984258
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/984258 | Pharmaceutical composition for prevention or treatment of diabetes or fatty liver comprising CYP4A inhibitor | May 17, 2018 | Issued |
Array
(
[id] => 13397441
[patent_doc_number] => 20180250263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => THERAPEUTIC COMBINATIONS OF SESQUITERPENES AND FLAVONOIDS
[patent_app_type] => utility
[patent_app_number] => 15/968790
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15968790
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/968790 | Therapeutic combinations of sesquiterpenes and flavonoids | May 1, 2018 | Issued |
Array
(
[id] => 13371771
[patent_doc_number] => 20180237426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/959686
[patent_app_country] => US
[patent_app_date] => 2018-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15959686
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/959686 | Heteroaryl compounds as IRAK inhibitors and uses thereof | Apr 22, 2018 | Issued |
Array
(
[id] => 15449313
[patent_doc_number] => 10548887
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => Pharmaceutical composition and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/958440
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 5844
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15958440
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/958440 | Pharmaceutical composition and uses thereof | Apr 19, 2018 | Issued |
Array
(
[id] => 13925989
[patent_doc_number] => 20190046510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 15/915940
[patent_app_country] => US
[patent_app_date] => 2018-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15915940
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/915940 | NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR | Mar 7, 2018 | Abandoned |
Array
(
[id] => 14213721
[patent_doc_number] => 20190119245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => INDOLE CARBOXAMIDE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/886192
[patent_app_country] => US
[patent_app_date] => 2018-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52365
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15886192
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/886192 | Indole carboxamide compounds | Jan 31, 2018 | Issued |
Array
(
[id] => 12769813
[patent_doc_number] => 20180148439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => DEUTERATED O-SULFATED BETA LACTAM HYDROXAMIC ACIDS AND DEUTERATED N-SULFATED BETA LACTAMS
[patent_app_type] => utility
[patent_app_number] => 15/878689
[patent_app_country] => US
[patent_app_date] => 2018-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15878689
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/878689 | Deuterated O-sulfated beta lactam hydroxamic acids and deuterated N-sulfated beta lactams | Jan 23, 2018 | Issued |
Array
(
[id] => 12233111
[patent_doc_number] => 20180065975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF OXYCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/812730
[patent_app_country] => US
[patent_app_date] => 2017-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 13536
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15812730
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/812730 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone, prodrugs, methods of making and use thereof | Nov 13, 2017 | Issued |
Array
(
[id] => 12675628
[patent_doc_number] => 20180117042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => METHODS FOR TREATING RESPIRATORY SYNCYTIAL VIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 15/795079
[patent_app_country] => US
[patent_app_date] => 2017-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16137
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15795079
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/795079 | METHODS FOR TREATING RESPIRATORY SYNCYTIAL VIRUS INFECTION | Oct 25, 2017 | Abandoned |
Array
(
[id] => 12183921
[patent_doc_number] => 20180042856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'Natural Lubricant for Direct Compression and Method for Preparing Natural Tablet Using the Same'
[patent_app_type] => utility
[patent_app_number] => 15/794684
[patent_app_country] => US
[patent_app_date] => 2017-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3251
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15794684
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/794684 | Natural lubricant for direct compression and method for preparing natural tablet using the same | Oct 25, 2017 | Issued |
Array
(
[id] => 13699469
[patent_doc_number] => 20170360689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => DELIVERY OF HYDROPHOBIC BIOACTIVE AGENTS
[patent_app_type] => utility
[patent_app_number] => 15/696928
[patent_app_country] => US
[patent_app_date] => 2017-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15696928
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/696928 | Delivery of hydrophobic bioactive agents | Sep 5, 2017 | Issued |